Cargando…

Pathophysiology of Non Alcoholic Fatty Liver Disease

The physiopathology of fatty liver and metabolic syndrome are influenced by diet, life style and inflammation, which have a major impact on the severity of the clinicopathologic outcome of non-alcoholic fatty liver disease. A short comprehensive review is provided on current knowledge of the pathoph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petta, Salvatore, Gastaldelli, Amalia, Rebelos, Eleni, Bugianesi, Elisabetta, Messa, Piergiorgio, Miele, Luca, Svegliati-Baroni, Gianluca, Valenti, Luca, Bonino, Ferruccio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187882/ https://www.ncbi.nlm.nih.gov/pubmed/27973438 http://dx.doi.org/10.3390/ijms17122082

Ejemplares similares

Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research
por: Mancini, Marcello, et al.
Publicado: (2018)

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
por: Gaggini, Melania, et al.
Publicado: (2013)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
por: Svegliati-Baroni, Gianluca, et al.
Publicado: (2020)

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease
por: Pennisi, Grazia, et al.
Publicado: (2023)

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
por: Dongiovanni, Paola, et al.
Publicado: (2018)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
por: Bianco, Cristiana, et al.
Publicado: (2021)

Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2022)

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
por: McGlinchey, Aidan J., et al.
Publicado: (2022)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease
por: Gaggini, Melania, et al.
Publicado: (2019)

A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
por: Dongiovanni, Paola, et al.
Publicado: (2017)

Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease
por: Fracanzani, Anna Ludovica, et al.
Publicado: (2012)

Natural history of NASH
por: Armandi, Angelo, et al.
Publicado: (2021)

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
por: Donati, Benedetta, et al.
Publicado: (2017)

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
por: Mandato, Claudia, et al.
Publicado: (2022)

Urinary lithogenic profile of patients with non-alcoholic fatty liver disease
por: Bargagli, Matteo, et al.
Publicado: (2023)

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
por: Romero-Gómez, Manuel, et al.
Publicado: (2023)

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease
por: Bayoumi, Ali, et al.
Publicado: (2020)

Diet and Exercise in the Treatment of Fatty Liver
por: Magkos, Faidon, et al.
Publicado: (2012)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
por: Fianchi, Francesca, et al.
Publicado: (2021)

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
por: Ceccarelli, Sara, et al.
Publicado: (2015)

Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area
por: Mocchegiani, Federico, et al.
Publicado: (2020)

Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2022)

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis
por: Turola, Elena, et al.
Publicado: (2015)

PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2013)

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications
por: Ciardullo, Stefano, et al.
Publicado: (2020)

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
por: Golabi, Pegah, et al.
Publicado: (2019)

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
por: Benfaremo, Devis, et al.
Publicado: (2022)

Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Castelnuovo, Gabriele, et al.
Publicado: (2023)

The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives
por: Pennisi, Grazia, et al.
Publicado: (2019)

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
por: Hyötyläinen, Tuulia, et al.
Publicado: (2016)

Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
por: Foglia, Beatrice, et al.
Publicado: (2019)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dajgf1drh67dji6nh1fftuhhhi